Your session is about to expire
← Back to Search
Behavioral Intervention
Heartfulness Meditation for Cyclic Vomiting Syndrome (HFN in CVS Trial)
N/A
Recruiting
Research Sponsored by Ohio State University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 weeks
Awards & highlights
HFN in CVS Trial Summary
This trial examines a technique to reduce psychological distress and improve HRQoL in people with Cyclic Vomiting Syndrome. It suggests that Heartfulness Meditation may help reduce stress and improve well-being in those affected.
Who is the study for?
This trial is for adults aged 18-80 with Cyclic Vomiting Syndrome (CVS) as per Rome criteria. It's not suitable for those with severe heart/lung diseases, kidney failure on dialysis, recent suicidal behavior, cognitive issues preventing meditation, major uncontrolled psychiatric illnesses, inability to sit for 30 minutes, certain other health conditions or high/low BMI.Check my eligibility
What is being tested?
The study tests Heartfulness meditation—a free guided technique focusing on relaxation and the heart—to see if it reduces stress and improves quality of life in CVS patients. The effects of this meditation practice on psychological distress and coping strategies are also being studied.See study design
What are the potential side effects?
Heartfulness meditation is generally considered safe but may cause discomfort due to sitting still for long periods. Some individuals might experience increased emotional sensitivity or awareness during the process.
HFN in CVS Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 6 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 weeks
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Acute physiological effects of HFN Meditation on the endocannabinoid signaling system (ECSS)
Correlate indices of ECSS with psychological state
Secondary outcome measures
Long-term effects of HFN Meditation on the ECSS and correlation with psychological outcomes
HFN in CVS Trial Design
1Treatment groups
Experimental Treatment
Group I: HFN MeditationExperimental Treatment1 Intervention
Subjects will complete guided meditation sessions 3 x a week for six weeks delivered in the app via video, as well as pre- and post-meditation psychological state assessments.
Find a Location
Who is running the clinical trial?
Ohio State UniversityLead Sponsor
828 Previous Clinical Trials
505,711 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You have tried to harm yourself or have had thoughts about hurting yourself in the past year.You have difficulty thinking or remembering things, which makes it hard for you to focus and meditate.You use cannabis every day or almost every day.You have been practicing meditation regularly for at least 3 months within the past year.You have been diagnosed with a condition called CVS according to specific criteria called the Rome criteria.You have serious heart or lung problems, cancer, or are undergoing dialysis for kidney failure.You have other gastrointestinal or systemic diseases, like inflammatory bowel disease or chronic liver disease.Your body mass index (BMI) is either too low or too high.
Research Study Groups:
This trial has the following groups:- Group 1: HFN Meditation
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is the enrollment period for this trial still ongoing?
"The clinical trial, first made available on June 6th 2022, is still actively recruiting patients according to information provided by clinicaltrials.gov. The listing was most recently amended on July 18th 2023."
Answered by AI
Does this research extend to individuals under the age of 65?
"The age range for potential participants in this medical trial spans from 18 to 80 years old."
Answered by AI
Is there room for me to join this clinical trial?
"Individuals with cyclic vomiting syndrome, aged between 18 and 80, are eligible to apply for the study. The total number of participants sought is estimated at 40."
Answered by AI
To what extent is the scope of this experiment in terms of participant numbers?
"Affirmative. The clinicaltrials.gov registry indicates that the study, which was initiated on June 6th 2022, is actively seeking participants. Approximately 40 patients must be enrolled from a single medical site."
Answered by AI
Who else is applying?
What site did they apply to?
The Ohio State University
What portion of applicants met pre-screening criteria?
Did not meet criteria
Met criteria
Why did patients apply to this trial?
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger